Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesisJason W. Locasale, Matthew G. Vander Heiden, Alexandra Grassian et al.|Nature Genetics|2011Cited by 1.1k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Eliezer M. Van Allen, Claire A. Margolis et al.|Nature Genetics|2018Cited by 701
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression LevelsBiagio Ricciuti, Mark M. Awad, Justin F. Gainor et al.|JAMA Oncology|2022Cited by 383